Wegovy is a breakthrough medication for chronic weight management that, when combined with a reduced-calorie diet and increased physical activity, can lead to significant and sustained weight loss. As a weekly injection, Wegovy's active ingredient, semaglutide, works by mimicking a natural hormone called GLP-1. This action helps to regulate appetite and food intake, leading to feelings of fullness and a reduction in cravings. Clinical trials have demonstrated the effectiveness of this approach in helping adults with a high BMI achieve their weight loss goals and improve their overall health. Wegovy is a powerful option for those ready to commit to a healthier lifestyle and requires a prescription from a healthcare provider to ensure it's the right choice for you.
Wegovy is a pre-filled pen injected under the skin. Administer this medication into the abdomen, thigh, or upper arm once weekly, on the same day each week. Wegovy can be taken with or without food, and injection sites should be rotated with each dose. If you have type 2 diabetes, you may need to monitor your blood sugar before and during administration. Always follow the prescription label and your doctor's instructions. Ask for guidance if you have any questions or concerns.
Store Wegovy in the refrigerator. Do not freeze Wegovy. After using your Wegovy pen, discard it.
The usual starting dose is 0.25 mg weekly. After four weeks, your doctor may increase your dose stepwise, until you achieve the recommended weekly maintenance dose of 2.4 mg.
The active ingredient in Wegovy is semaglutide.
Avoid using Wegovy if you or a member of your family has had thyroid carcinoma (MTC), a type of thyroid cancer, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Avoid using Wegovy if you are allergic to semaglutide or any of the other ingredients contained in Wegovy.
Avoid using Wegovy with other GLP-1 agonists.
Avoid using Wegovy if you have type 1 diabetes.
Discuss your medications, allergies, medical problems, and pregnancy or breastfeeding status with your doctor before you begin treatment with Wegovy.
Be cautious if you have any of the following:
Kidney problems
Gallbladder disease
Pancreatic problems
History of diabetic retinopathy
Currently have or have had a history of mental health problems.
Use with caution if you have severe gastrointestinal disease.
Inform your doctor immediately if you have persistent or worsening adverse effects. Some side effects associated with Wegovy include:
Nausea
Vomiting
Diarrhea
Constipation
Stomach pain
Headache
Tiredness
Bloating
Wegovy is a breakthrough medication for chronic weight management that, when combined with a reduced-calorie diet and increased physical activity, can lead to significant and sustained weight loss. As a weekly injection, Wegovy's active ingredient, semaglutide, works by mimicking a natural hormone called GLP-1. This action helps to regulate appetite and food intake, leading to feelings of fullness and a reduction in cravings. Clinical trials have demonstrated the effectiveness of this approach in helping adults with a high BMI achieve their weight loss goals and improve their overall health. Wegovy is a powerful option for those ready to commit to a healthier lifestyle and requires a prescription from a healthcare provider to ensure it's the right choice for you.
Wegovy is a pre-filled pen injected under the skin. Administer this medication into the abdomen, thigh, or upper arm once weekly, on the same day each week. Wegovy can be taken with or without food, and injection sites should be rotated with each dose. If you have type 2 diabetes, you may need to monitor your blood sugar before and during administration. Always follow the prescription label and your doctor's instructions. Ask for guidance if you have any questions or concerns.
Store Wegovy in the refrigerator. Do not freeze Wegovy. After using your Wegovy pen, discard it.
The usual starting dose is 0.25 mg weekly. After four weeks, your doctor may increase your dose stepwise, until you achieve the recommended weekly maintenance dose of 2.4 mg.
The active ingredient in Wegovy is semaglutide.
Avoid using Wegovy if you or a member of your family has had thyroid carcinoma (MTC), a type of thyroid cancer, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Avoid using Wegovy if you are allergic to semaglutide or any of the other ingredients contained in Wegovy.
Avoid using Wegovy with other GLP-1 agonists.
Avoid using Wegovy if you have type 1 diabetes.
Discuss your medications, allergies, medical problems, and pregnancy or breastfeeding status with your doctor before you begin treatment with Wegovy.
Be cautious if you have any of the following:
Kidney problems
Gallbladder disease
Pancreatic problems
History of diabetic retinopathy
Currently have or have had a history of mental health problems.
Use with caution if you have severe gastrointestinal disease.
Inform your doctor immediately if you have persistent or worsening adverse effects. Some side effects associated with Wegovy include:
Nausea
Vomiting
Diarrhea
Constipation
Stomach pain
Headache
Tiredness
Bloating
Disclaimer: The information provided is for general awareness and educational purposes only. It is not intended to diagnose, treat, or replace professional medical advice. Always consult your physician or pharmacist regarding the safety, suitability, and proper use of any medication.
